deoxyepinephrine has been researched along with Disease Models, Animal in 8 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To examine the influence of the oral dopamine agonist ibopamine on these factors, we studied 20 rats with chronic myocardial infarction and CHF, and compared them with 20 normal rats." | 7.69 | Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure. ( Buikema, H; de Graeff, PA; de Smet, BJ; Girbes, AR; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H, 1994) |
| "Increased plasma noradrenaline concentrations in rats with myocardial infarction and aortic stenosis were reduced by ibopamine." | 7.68 | Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. ( Buikema, H; de Smet, BJ; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H, 1993) |
| "Ibopamine is an orally active dopamine agonist (DA) with both hemodynamic and neurohumoral properties in humans." | 5.29 | Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril. ( Buikema, H; de Graeff, PA; Hegeman, H; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ, 1994) |
| " To examine the influence of the oral dopamine agonist ibopamine on these factors, we studied 20 rats with chronic myocardial infarction and CHF, and compared them with 20 normal rats." | 3.69 | Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure. ( Buikema, H; de Graeff, PA; de Smet, BJ; Girbes, AR; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H, 1994) |
| "Increased plasma noradrenaline concentrations in rats with myocardial infarction and aortic stenosis were reduced by ibopamine." | 3.68 | Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. ( Buikema, H; de Smet, BJ; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H, 1993) |
| "Ibopamine is an orally active dopamine agonist (DA) with both hemodynamic and neurohumoral properties in humans." | 1.29 | Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril. ( Buikema, H; de Graeff, PA; Hegeman, H; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Mueller, M | 1 |
| Yuan, J | 1 |
| Felim, A | 1 |
| Neudörffer, A | 1 |
| Peters, FT | 1 |
| Maurer, HH | 1 |
| McCann, UD | 1 |
| Largeron, M | 1 |
| Ricaurte, GA | 1 |
| van Gilst, WH | 5 |
| van Veldhuisen, DJ | 5 |
| Hegeman, H | 2 |
| Buikema, H | 3 |
| Scholtens, E | 5 |
| de Graeff, PA | 3 |
| Lie, KI | 4 |
| Brodde, OE | 1 |
| Schulze, C | 1 |
| Anthonio, RL | 1 |
| Wesseling, H | 3 |
| de Smet, BJ | 2 |
| Girbes, AR | 1 |
| Teisman, AC | 1 |
| Maselbas, W | 1 |
8 other studies available for deoxyepinephrine and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Deoxyepinephrine; Disease Models, Animal; Male; N-Methyl-3,4 | 2009 |
Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril.
Topics: Animals; Captopril; Catecholamines; Coronary Circulation; Deoxyepinephrine; Disease Models, Animal; | 1994 |
Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chronic Dise | 1995 |
Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Chronic Disease; Deoxyepinep | 1994 |
Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
Topics: Animals; Aortic Valve Stenosis; Culture Techniques; Deoxyepinephrine; Disease Models, Animal; Endoth | 1993 |
Effects of selective dopaminergic receptor stimulation on ventricular remodeling after experimental myocardial infarction in rats.
Topics: Animals; Deoxyepinephrine; Disease Models, Animal; Dopamine Agonists; Heart Ventricles; Hemodynamics | 1997 |